Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression

Neurology

Volumn 45, Issue 11, 1995, Pages 1962-1964

  Wijdicks, Eelco F M ^a   Wiesner, Russell H ^a   Krom, Ruud A F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEUROLOGIC DISEASE;

ADOLESCENT; ADULT; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES;

EID: 0029400646     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.45.11.1962     Document Type: Article

References (18)

1. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (first of two parts). N Engl J Med 1989;321:1014–1022.
2. de Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RA. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 1987; 317:861–866.
3. Bronster DJ, Emre S, Mor E, Sheiner P, Miller CM, Schwartz ME. Neurologic complications of orthotopic liver transplantation. Mt Sinai J Med 1994;61:63–69.
4. Boon AP, Adams DH, Carey MP, Williams A, McMaster P, Elias E. Cyclosporin-associated cerebral lesions in liver transplantation [letter]. Lancet 1988;1:1457.
5. Bird GL, Meadows J, Goka J, Poison R, Williams R. Cy- closporine-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry 1990;53:1068–1071.
6. Appleton RE, Farrell K, Teal P, Hashimoto SA, Wong PK. Complex partial status epilepticus associated with cyclosporine A therapy. J Neurol Neurosurg Psychiatry 1989; 52:1068–1071.
7. Adams DH, Ponsford S, Gunson B, et al. Neurological complications following liver transplantation. Lancet 1987; 1:949–951.
8. Eidelman BH, Abu-Elmagd K, Wilson J, et al. Neurologic complications of FK 506. Transplant Proc 1991;23:3175–3178.
9. Gottrand F, Largilliere C, Farriaux JP. Cyclosporine neurotoxicity [letter]. N Engl J Med 1991;324:1744–1745.
10. Lane RJ, Roche SW, Leung AA, Greco A, Lange LS. Cyclosporin neurotoxicity in cardiac transplant recipients. J Neurol Neurosurg Psychiatry 1988;51:1434–1437.
11. Lind MJ, McWilliam L, Jip J, Scarffe JH, Morgenstern GR, Chang J. Cyclosporin associated demyelination following allogeneic bone marrow transplantation. Hematol Oncol 1989; 7:49–52.
12. Moreno E, Gomez SR, Gonzalez I, et al. Neurologic complications in liver transplantation. Acta Neurol Scand 1993; 87:25–31.
13. Rowley HA, Kaku DA, Ascher NL, Roberts JP, Lake JR. Neurologic findings in 100 consecutive liver transplant recipients [abstract]. Neurology 1990;40(suppl 1):181.
14. Steg RE, Garcia EG. Complex visual hallucinations and cyclosporine neurotoxicity. Neurology 1991;41:1156.
15. Stein DP, Lederman RJ, Vogt DP, Carey WD, Broughan TA. Neurological complications following liver transplantation. Ann Neurol 1992;31:644–649.
16. Truwit CL, Denaro CP, Lake JR, DeMarco T. MR imaging of reversible cyclosporine A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651–659.
17. Pujol A, Graus F, Rimola A, et al. Predictive factors of inhospital CNS complications following liver transplantation. Neurology 1994;44:1226–1230.
18. Wijdicks EF, Wiesner RH, Dahlke LJ, Krom RA. FK506-in- duced neurotoxicity in liver transplantation. Ann Neurol 1994;35:498–501.